PAREXEL International Corporation ( PRXL ), a provider of biopharmaceutical services, recently acquired all the outstanding equity securities of Liquent, a worldwide provider of
See more here:
PRXL Closes Buyout, Yields Outlook (revised) – Analyst Blog